Clinical and histological patterns and treatment of pyoderma gangrenosum

被引:10
|
作者
Chakiri, Radia [1 ]
Baybay, Hanane [1 ]
El Hatimi, Asmae [1 ]
Gallouj, Salim [1 ]
Harmouch, Taoufiq [2 ]
Mernissi, Fatima Zohra [1 ]
机构
[1] Univ Hosp Hassan II, Dept Dermatol, Fes, Morocco
[2] Univ Hosp Hassan II, Dept Anatomopathol, Fes, Morocco
来源
关键词
Pyoderma gangrenosum; neutrophilic dermatosis; systemic disease; MANAGEMENT; COMORBIDITIES;
D O I
10.11604/pamj.2020.36.59.12329
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Pyoderma gangrenosum (PG) is a rare inflammatory neutrophilic dermatosis for which accurate epidemiological data are limited and therapy remains a challenge. The primary study's aim was to examine all cases of PG observed in our department over a 6-year period in order to describe the relevant characteristics and outcome under therapy. Fourteen patients were included (5 women, 9 men). The average age of our patients was 40,15 years. The classical, ulcerative form was found in 10 cases (71.42%), the pustular form in 4 cases (27.57%) and PG was multifocal in 4 cases. The PG was located preferentially to the lower limbs. Histological examination was realized in all patients and objectified inflammatory infiltrate composed of polymorphonuclear neutrophils in all cases with vasculitis in 4 cases. Six patients (42.85%) had associated disease at diagnosis of PG, including inflammatory bowel disease in two cases (14.28%), a blood disease in 2 cases (14.28%), lymph node tuberculosis and inflammatory arthritis in 1 case (7%). The most frequent first-line treatments were oral corticosteroids (7 cases) and other treatments used were colchicine in 2 cases, topical corticosteroids in 3 cases with good clinical evolution. Our study confirms that PG is a rare disease, associated in almost half of cases with systemic disease already present at diagnosis; in our Moroccan background, it is most often inflammatory bowel disease, hematological or solid cancer and tuberculosis.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Clinical patterns and treatment of pyoderma gangrenosum in a French department
    Anuset, D.
    Reguiai, Z.
    Perceau, G.
    Colomb, M.
    Durlach, A.
    Bernard, P.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2016, 143 (02): : 108 - 117
  • [2] Treatment of pyoderma gangrenosum
    Chow, RKP
    Ho, VC
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1996, 34 (06) : 1047 - 1060
  • [3] Treatment of pyoderma gangrenosum
    Anstey, AV
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1997, 36 (05) : 802 - 802
  • [4] Treatment of Pyoderma Gangrenosum
    Tan, Marcus G.
    Tolkachjov, Stanislav N.
    DERMATOLOGIC CLINICS, 2024, 42 (02) : 183 - 192
  • [5] Treatment of pyoderma gangrenosum
    Mekkes, Jan Robert
    BMJ-BRITISH MEDICAL JOURNAL, 2015, 350
  • [6] Diagnosis and novel clinical treatment strategies for pyoderma gangrenosum
    Goldust, Mohamad
    Hagstrom, Erika L.
    Rathod, Dipali
    Ortega-Loayza, Alex G.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2020, 13 (02) : 157 - 161
  • [7] Malignant pyoderma: A clinical variant of pyoderma gangrenosum
    Erdi, H
    Anadolu, R
    Piskin, G
    Gurgey, E
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 1996, 35 (11) : 811 - 813
  • [8] Clinical management of pyoderma gangrenosum
    Wollina U.
    American Journal of Clinical Dermatology, 2002, 3 (3) : 149 - 158
  • [9] Pyoderma gangrenosum: a clinical conundrum
    Abdelmaksoud, A.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (10) : E381 - E382
  • [10] Pyoderma Gangrenosum: Treatment Options
    Dissemond, Joachim
    Marzano, Angelo V.
    Hampton, Philip J.
    Ortega-Loayza, Alex G.
    DRUGS, 2023, : 1255 - 1267